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Langerhans Cells Are Required for UVR-Induced
Immunosuppression
Agatha Schwarz1, Madelon Noordegraaf2,3, Akira Maeda4, Kan Torii4, Bjo¨rn E. Clausen2,3 and
Thomas Schwarz1
Painting of haptens onto UVR-exposed skin does not result in sensitization but induces regulatory T cells (Treg).
This was explained by UVR-mediated depletion of Langerhans cells (LCs). Furthermore, migration of UVR-
damaged but still viable LCs into lymph nodes appears to be essential to induce Treg. Accordingly, the steroid
mometasone, which kills LCs, inhibited sensitization but did not induce Treg. In Langerin-diphtheria toxin
receptor knock-in (DTR) mice, LCs can be depleted by injection of diphtheria toxin (DT). LC-depleted mice
could be sensitized though less pronounced than wild-type mice, but sensitization was not suppressed by UVR.
Similarly, Treg did not develop. Langerin is not only expressed in LCs but also in some dermal dendritic cells
(dDCs). Langerin-positive dDCs repopulate within 10 days after depletion, whereas LCs are still absent.
Langerin-DTR mice treated with DT 10 days before UVR and sensitization were still resistant to UVR-induced
inhibition of contact hypersensitivity (CHS). Similarly, Treg did not arise. As in this setting only LCs but not
Langerin-positive dDCs are absent, LCs appear to be essential for both the suppression of CHS and the
induction of Treg by UVR. This supports the concept that LCs are more important for the downregulation than
the induction of immune responses in the skin.
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INTRODUCTION
UVR, in particular the mid-wave range (UVB, 290–320 nm),
is well known for its immunosuppressive properties that
mostly affect T cell-mediated immune reactions. UVR-
mediated immunosuppression is most convincingly demon-
strated by the inhibition of contact hypersensitivity (CHS).
Toews et al. (1980) observed that UVR inhibits the sensitiza-
tion to contact allergens if they are applied directly onto the
UVR-exposed skin areas. In addition, the very same animals
could not be sensitized against the same hapten at a later time
point without further UVR exposure. As other immune
reactions were not suppressed, this suggested the develop-
ment of hapten-specific tolerance (Toews et al., 1980). In
those days, Langerhans cells (LCs) were considered as the
exclusive antigen-presenting cells in the skin (Stingl et al.,
1980). As LCs were found to be depleted on UVR exposure
(Toews et al., 1980; Aberer et al., 1981), inhibition of
sensitization was explained simply by the absence of LCs.
Today the situation appears less clear, as a variety of studies
have challenged the exclusive role of LC as antigen-
presenting cells of the skin (Allan et al., 2003; Bennett
et al., 2005; Kaplan et al., 2005; Kissenpfennig et al., 2005).
UVR-induced immunologic unresponsiveness can be
adoptively transferred by injection of splenocytes and lymph
node cells obtained from UVR-tolerized mice into naive
mice, which subsequently cannot be sensitized against the
respective hapten (Elmets et al., 1983). This indicated that
UVR-induced tolerance is mediated through the induction of
hapten-specific T suppressor cells, which are nowadays
called regulatory T cells (Treg) (Schwarz, 2008).
UVR-induced Treg (UVR-Treg), which suppress hapten-
mediated CHS, are quite well characterized. They express
CD4 and CD25 (Schwarz et al., 2004), the negative
regulatory molecule CTLA-4 (Schwarz et al., 2000), gluco-
corticoid-induced tumor necrosis factor receptor (Maeda
et al., 2008a), and bind the lectin dectin-2 (Aragane et al.,
2003). In addition, they secrete IL-10 on hapten-specific
stimulation (Schwarz et al., 2000, 2004) and may use the
apoptosis-related Fas/Fas-ligand system (Schwarz et al.,
1998). As UVR-Treg suppress in an antigen-specific manner,
they harbor therapeutic potential for the treatment of
(auto)immune-mediated disorders.
With regard to their antigen specificity, UVR-Treg differ
from natural Treg (Sakaguchi et al., 2008) but also from
immunosuppressive drugs that cause immunosuppression
in a general manner. Therefore, we are interested (i) in
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further characterizing UVR-Treg and (ii) in clarifying the
mechanisms by which UVR-Treg are induced. The latter
appears to be critically dependent on the migration of LC into
the lymph nodes and the presence of UVR-induced DNA
damage in the LC (Schwarz et al., 2005). This was confirmed
by the observation that IL-12, which reduces UVR-mediated
DNA damage (Schwarz et al., 2002; Meeran et al., 2006a, b),
prevents the generation of UVR-Treg (Schmitt et al., 1995;
Schwarz et al., 1996). These findings gave rise to the
hypothesis that the appearance of UVR-damaged but still
viable LC in the regional lymph nodes is an essential event
during the generation of UVR-Treg.
If this holds true, a stimulus that does not damage but
definitely kills LC should prevent the induction of UVR-Treg.
To clarify this issue we used the steroid mometasone in this
study. To further substantiate the crucial role of LC for the
generation of UVR-Treg, Langerin-diphtheria toxin receptor
knock-in (Langerin-DTR) mice were used, in which LC can be
depleted by the injection of diphtheria toxin (DT). We
postulated that according to our hypothesis UVR-Treg should
not develop in LC-depleted mice.
RESULTS
Mometasone inhibits the induction of CHS but does not induce
Treg
Topical corticosteroids are well known to effectively kill LC
by inducing apoptosis (Grabbe et al., 1995; Hoetzenecker
et al., 2004). Thus, we used the steroid derivative mometa-
sone. Topical application of mometasone (0.1% for 4 days)
depleted LC, as demonstrated by immunohistochemical
staining of skin sheet preparations obtained 24 hours after
the last steroid administration (Figure 1a). To differentiate
whether mometasone causes depletion of LC by inducing
emigration from the epidermis into the lymph nodes or
simply by killing LC, draining lymph nodes were collected
after mometasone application. Lymph node cell suspensions
were stained with antibodies against Langerin and CD11c. In
lymph nodes of untreated mice, a small number of Langerin-
positive cells was detected (Figure 1b), confirming previous
results (Schwarz et al., 2005). In contrast, no Langerin-
positive cells were found in the lymph nodes on steroid
application. This indicates that steroids, in contrast to low-
dose UVR, deplete LC from the epidermis not through
inducing emigration into the lymph nodes but by killing LC.
Mice were sensitized by painting DNFB onto mometa-
sone-pretreated skin. Ear challenge was performed 5 days
later and ear swelling measured 24 hours thereafter. Positive
control mice were sensitized through untreated skin and
reacted with a pronounced ear swelling response upon
challenge (Figure 2a). Negative control mice were only
challenged without sensitization and did not react with ear
swelling, excluding a toxic reaction. Mice that were
sensitized with DNFB through mometasone-treated skin
revealed a significantly reduced ear swelling response,
indicating that topical steroids prevent efficient sensitization.
To address whether Treg developed in the mometasone-
treated mice, adoptive transfer experiments were performed.
The above-mentioned experiment was repeated. Five days
after sensitization, spleen and lymph node cells were
obtained from mometasone-treated donors and injected
intravenously into naive mice. Recipients were sensitized
against DNFB 24hours after cell transfer, and ear challenge
was performed 5 days later. Mice that had received cells
obtained from mometasone-treated donors responded with a
pronounced ear swelling response comparable to that of
positive control mice (Figure 2b). Thus, Treg did not develop
in mometasone-treated donors. Together, this indicates that
mometasone similar to UVR prevents the induction of CHS
but in contrast to UVR does not induce Treg.
Langerin-DTR mice are resistant to UVR-induced
immunosuppression
The data depicted in Figure 2 support our hypothesis that for
the development of Treg, damaged but still viable LC are
required. However, one cannot exclude the fact that
mometasone affects not only LC but also other cells, which
could influence the adoptive transfer experiments. To further
elucidate the role of LC in the development of UVR-Treg, we
used Langerin-DTR mice. These mice harbor a targeted
insertion of the human DTR into the langerin locus (Bennett
et al., 2005). As the cytotoxicity of DT is strictly dependent on
receptor-mediated endocytosis (Naglich et al., 1992), and as
murine cells are resistant to DT due to low affinity of the toxin
for the rodent DTR, injection of DT into Langerin-DTR mice
results in complete depletion of LC (Figure 3a). Thus, we
postulated that if LCs are crucially required for the induction
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Figure 1. Mometasone depletes LCs. (a) Mice were treated on their ears with
0.1% mometasone for 4 days. Twenty-four hours after the last mometasone
application, ears were collected and ear sheets prepared. Ear sheets were
stained with an antibody directed against major histocompatibility
complex class II. Untreated mice served as controls (Co). Bars¼ 200mm.
(b) Mometasone was applied on the shaved back for 4 days. Twenty-four
hours after the last mometasone application, draining lymph nodes were
obtained. Cell suspensions were stained with antibodies directed against
Langerin and CD11c and subjected to FACS analysis.
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of UVR-Treg, they should not develop in DT-treated
Langerin-DTR mice.
Langerin-DTR mice were injected with DT. After 72 hours,
mice were exposed to UVR (150mJ cm2) on 4 consecutive
days. After 24 hours, the last exposure animals were
sensitized with DNFB through irradiated skin. After 5 days,
animals were challenged on the left ear and ear swelling was
measured 24 hours later. DT-treated Langerin-DTR mice,
which were either sensitized and challenged or challenged
only, were included as controls. Additional control groups
included Langerin-DTR mice, which did not receive DT but
were otherwise treated identically. These mice behaved
similar to wild-type animals (Figure 3c). The positive control
mice responded with a significant ear swelling response to
sensitization (#1) in comparison to negative control mice,
which were challenged only (#2). Mice that were sensitized
through skin exposed to low-dose UVR, which effectively
depletes LC from the epidermis (Figure 3b), were significantly
suppressed in their CHS response (#3, Figure 3c). Mice in
which LC were depleted by DT injection could be sensitized
(#4), although the sensitization response was weaker than in
mice that did not receive DT (#1), thus confirming previous
observations (Bennett et al., 2005, 2007). Surprisingly, UVR-
exposure of LC-depleted mice did not result in suppression of
CHS (#6, Figure 3c). These mice revealed an equally
pronounced ear swelling response as DT-treated mice, which
were sensitized without UVR exposure (#4). Similar data
were obtained when UVR exposure was initiated 24 hours
instead of 72 hours after DT injection (data not shown).
To determine whether UV-Treg developed in these mice,
lymph nodes and spleens were obtained from the UVR-
exposed mice (#3, #6 of Figure 3c). Cells were injected
intravenously into wild-type mice. Recipients were sensitized
against DNFB 24hours later. After 5 days, mice were
challenged on the left ear and ear swelling was evaluated
24 hours later. Positive control mice comprised wild-type
mice that were sensitized and challenged (Figure 4, #1),
whereas negative control mice were challenged only (#2).
Mice (#3) injected with cells from UVR-exposed donors,
which were not treated with DT (UVR), revealed a
remarkably suppressed CHS response, indicating that Treg
had developed in the donors (Figure 4, #3). In contrast,
recipients of cells from LC-depleted donors which were
sensitized through UVR-exposed skin (UVRþDT) responded
with a significant ear swelling response to sensitization
(Figure 4, #4). This indicates that in the LC-depleted donors
Treg did not develop. Together, these data imply that UVR-
induced immunosuppression is critically dependent on LC.
As the rodent DT receptor exhibits only low affinity to DT,
wild-type mice do not respond to DT (Bennett and Clausen,
2007). However, DT may be contaminated with toll-like
receptor ligands and thus could affect the CHS response. To
exclude this, C57BL/6 mice were treated with DT, UV-
exposed, and sensitized, as described above. Positive control
mice were treated with DT, sensitized, and challenged
(Figure 5, #1). Negative control mice were injected with
DT but only challenged (#2). The ear swelling responses of
positive control mice (#1) did not differ from those observed
in wild-type mice (#4), which were sensitized but had not
received DT (Figure 5). Similarly, suppression of the
induction of CHS by UVR was not affected by DT in wild-
type animals (#6).
Langerin-positive dermal dendritic cells are not required for
UVR-induced immunosuppression
Although Langerin was initially described as a specific and
exclusive marker for LC (Valladeau et al., 2000; Takahara
et al., 2002), it recently turned out that other cells than LC
can express Langerin as well (Bursch et al., 2007; Ginhoux
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Figure 2. Mometasone inhibits the induction of CHS but does not induce
Treg. (a) Mice were treated on their razor-shaved back skin with mometasone
for 4 days. Twenty-four hours after the last application, mice were sensitized
on their backs with DNFB (Mometasone). Five days after sensitization, mice
were challenged with DNFB on the left ear. The ear swelling response was
measured 24 hours later. Positive control mice (Pos Co) were sensitized and
challenged, mice of the negative control (Neg Co) were challenged only.
CHS was determined as the amount of swelling of the hapten-challenged
ear compared with the thickness of the vehicle-treated ear and expressed
in cm  103 (mean±SD of one representative of three independent
experiments). Each group consisted of at least six mice. (b) Immediately after
the measurement of ear swelling, spleens and lymph nodes were obtained
from the mometasone-treated mice. Cells were injected intravenously into
naive recipients (transfer). After 24 hours, recipients were sensitized against
DNFB. Five days later, ear challenge was performed and ear swelling
measured 24 hours later. Positive control mice (Pos Co) were sensitized and
challenged, negative control mice (Neg Co) were challenged only. CHS was
determined as the amount of swelling of the hapten-challenged ear compared
with the thickness of the vehicle-treated ear and expressed in cm 103
(mean±SD of one representative of three independent experiments). Each
group consisted of at least six mice. *Po0.001 versus Pos Co.
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et al., 2007; Poulin et al., 2007; Nagao et al., 2009). This
applies mostly for dendritic cells in the dermis. There is
evidence that these cells do not represent LCs emigrating
from the epidermis but a separate subtype of dermal dendritic
cells (dDCs). Thus, these cells are also eliminated in
Langerin-DTR mice on injection of DT. Differences in the
behavior of LCs and Langerin-positive dDCs have been
described. After depletion with DT, Langerin-positive dDCs
repopulate within 10 days, whereas LCs are still absent
(Bursch et al., 2007). Similar kinetic analyses were performed
with our Langerin-DTR mice (M Noordegraaf et al., sub-
mitted). Forty-eight hours after DT injection, no LC and no
dDC could be detected. By day 10, around 22% of the dDCs
were found, but no LC. Fourteen days after injection, around
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Figure 3. Sensitization is not suppressed by UVR in LC-depleted mice.
(a) Langerin-DTR mice were injected with DT. After 72 hours, ears were
obtained and epidermal sheets were stained with an antibody directed against
major histocompatibility complex (MHC) class II. Untreated mice served as
controls. Bars¼ 100mm. (b) Langerin-DTR mice were exposed to UVR on
their ears. Twenty-four hours after the last irradiation, ears were obtained and
epidermal sheets were stained with an antibody directed against MHC class II.
Untreated mice served as controls. Bars¼ 100mm. (c) Langerin-DTR mice
were injected with DT. After 72 hours, mice were UVR-exposed for 4
consecutive days (UVR, #6). Twenty-four hours after the last UVR exposure,
mice were sensitized with DNFB painted onto UV-irradiated skin. After 5
days, animals were challenged on the left ear, and ear swelling was measured
24hours later. Positive control mice comprised DT-treated Langerin-DTR
mice, which were sensitized and challenged (DT, Pos Co, #4); negative
control mice were challenged only (DT, Neg Co, #5). As additional controls,
Langerin-DTR mice were treated identically but not injected with DT
(w/o DT, #1–3). CHS was determined as the amount of swelling of the
hapten-challenged ear compared with the thickness of the vehicle-treated
ear and expressed in cm 103 (mean±SD of one representative of three
independent experiments). Each group consisted of at least six mice.
*Po0.002 versus Pos Co; NS, not significant versus Pos Co.
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Figure 4. UVR-Treg do not develop in LC-depleted mice. Immediately after
measurement of ear swelling, spleens and regional lymph nodes were
obtained from UVR-exposed Langerin-DTR mice demonstrated in Figure 2
(#3, #6). Single cell suspensions were prepared and cells were injected
intravenously into naive C57BL/6 mice. Recipients were sensitized against
DNFB 24hours after injection (#3 UVR, #4 UVRþDT). Five days later, ear
challenge with DNFB was performed. Positive control mice (Pos Co)
comprised C57BL/6 mice, which were sensitized and challenged (#1);
negative control mice (Neg Co) were challenged only (#2). Ear swelling was
measured 24 hours later. CHS was determined as the amount of swelling of
the hapten-challenged ear compared with the thickness of the vehicle-treated
ear and expressed in cm 103 (mean±SD of one representative of three
independent experiments). Each group consisted of at least six mice.
*Po0.005 versus Pos Co; **Po0.05 versus UVRþDT; NS, not significant
versus Pos Co.
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Figure 5. DT does not affect CHS and UVR-induced immunosuppression in
wild-type mice. C57BL/6 mice were injected with DT. After 72 hours, mice
were exposed to UVR on their backs for 4 days. After 24 hours, the last
exposure DNFB was painted onto the UVR-exposed skin. Ear challenge was
performed 5 days later. Positive control mice (Pos Co) were injected with DT
and sensitized and challenged with DNFB. Negative control mice (Neg Co)
were injected with DT and challenged only. Ear swelling responses were
compared with groups that were treated identically but did not receive DT
(w/o DT). CHS was determined as the amount of swelling of the hapten-
challenged ear compared with the thickness of the vehicle-treated ear and
expressed in cm 103. *Po0.00005 versus Pos Co (w/o DT); **Po0.00002
versus Pos Co (DT).
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25% of the dDCs had reappeared and a few LC could be
visualized, as previously reported (Bennett et al., 2005;
Nagao et al., 2009).
To discern the role of Langerin-positive dDCs and LCs in
UVR-induced immunosuppression, Langerin-DTR mice were
treated with DT 10 days before UVR exposure (10d-DT). Ten
days were selected as according to our kinetic analysis, it is a
time point at which dDCs but no LC had reappeared. Mice
were exposed to UVR and sensitized as described above. As
expected, untreated UVR-exposed Langerin-DTR mice that
did not receive DT (Figure 6, #3) were suppressed in their
sensitization response when compared with positive control
mice (#1). Langerin-DTR mice that were treated with DT 10
days before the treatment still revealed a significant ear
swelling response (#4) when compared with negative control
mice (#5). However, the response was still ameliorated when
compared with Langerin-DTR mice that did not receive DT
(#1). This indicates that Langerin-positive dDCs, which
meanwhile have repopulated the skin, cannot fully compen-
sate for an efficient sensitization response. Even more
important, 10d-DT Langerin-DTR mice that were sensitized
through UVR-exposed skin (#6) were not at all suppressed in
their sensitization response when compared with positive
control mice (#4). This indicates that UVR-induced inhibition
of the induction of CHS does not depend on Langerin-positive
dDCs but on LCs.
To address whether Treg developed, splenocytes and
lymph node cells were obtained from the UVR-exposed
mice, displayed in Figure 6 (#3, #6). Cells were injected
intravenously into naive wild-type mice that were sensitized
24 hours after injection. Challenge was performed 5 days
later. As demonstrated in Figure 7, recipients that had
received cells from UVR-exposed donors that were not
treated with DT were suppressed in their sensitization
response (#3), indicating the development of UV-Treg in
the donors (#3, Figure 6). In contrast, mice that had received
cells from donors injected with DT 10 days before UVR
exposure were not suppressed in their sensitization response
(Figure 7, #4). This indicates that UVR-Treg had not
developed in the donors (#6, Figure 6). As in these donors
dDCs are already present but LCs still absent, one
can conclude that LCs are required for the development of
UVR-Treg.
DISCUSSION
UVR-Treg represent a special subtype of Treg (Beissert et al.,
2006). They differ from natural and induced Treg in many
aspects (Kabelitz et al., 2006; Sakaguchi et al., 2008). In
contrast to natural CD4þCD25þ Treg, which suppress in a
general manner, UVR-Treg suppress only when activated in
an antigen-specific manner. In addition, UVR-Treg have been
demonstrated not only to inhibit the induction but also the
elicitation phase of CHS, provided they can reach the skin
(Schwarz et al., 2004, 2007). Thus, UVR-Treg could represent
a suitable tool not only to prevent but also to treat
(auto)immune-mediated diseases. To achieve this aim, the
mechanisms by which they are induced need to be
elucidated.
We have recently proposed that the appearance of
damaged but still viable LC in the regional lymph nodes
is required for the development of UVR-Treg (Schwarz
et al., 2005). This was based on the observation that
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Figure 6. Dermal Langerin-positive cells are not involved in UVR-induced
immunosuppression. Langerin-DTR mice were injected with DT. Ten days
later, mice were UVR-exposed for 4 days (10d-DT, UVR, #6). Twenty-four
hours after the last UVR exposure, mice were sensitized with DNFB painted
onto UV-irradiated skin. After 5 days, animals were challenged on the left ear,
and ear swelling was measured 24 hours later. Positive control mice
comprised Langerin-DTR mice, which were injected with DT and sensitized
against DNFB 14 days after injection (10d-DTR, Pos Co, #4); negative control
mice were treated identically but not sensitized and challenged only (10d-
DTR, Neg Co, #5). As additional controls, Langerin-DTR mice were treated
identically but not injected with DT (w/o DT, #1–3). CHS was determined as
the amount of swelling of the hapten-challenged ear compared with the
thickness of the vehicle-treated ear and expressed in cm 103 (mean±SD of
one representative of three independent experiments). Each group consisted
of at least six mice. *Po0.0005 versus Pos Co (w/o DT); NS, not significant
versus Pos Co (10d-DTR).
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Figure 7. Dermal Langerin-positive cells are not involved in the
development of UVR-Treg. Immediately after measurement of ear swelling,
spleens and regional lymph nodes were obtained from the UVR-exposed
Langerin-DTR mice shown in Figure 4 (#3, #6). Single cell suspensions were
prepared, and cells were injected intravenously into naive C57BL/6 mice.
Recipients were sensitized against DNFB 24hours after injection (#3, #4).
Five days later, ear challenge with DNFB was performed. Positive control
mice (Pos Co) comprised C57BL/6 mice, which were sensitized and
challenged (#1); negative control mice (Neg Co) were challenged only (#2).
Ear swelling was measured 24hours later. CHS was determined as the amount
of swelling of the hapten-challenged ear compared with the thickness of the
vehicle-treated ear and expressed in cm103 (mean±SD of one
representative of three independent experiments). Each group consisted of at
least six mice. *Po0.005 versus Pos Co; NS, not significant versus Pos Co.
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Langerin-positive cells harboring UVR-specific DNA damage
(cyclobutane pyrimidine dimers, CPDs) could be detected in
mice that were sensitized through UVR-exposed skin and
subsequently developed UVR-Treg. On injection of IL-12,
which prevents the induction of UVR-Treg (Schmitt et al.,
1995; Schwarz et al., 1996), Langerin-positive cells were still
detected in the lymph nodes but did not contain CPDs;
consequently these mice did not develop UVR-Treg. The
reducing effect of IL-12 on the amounts of CPDs appears to
be mediated by nucleotide excision repair, the major repair
system for UVR-induced DNA damage, as IL-12 did not
reduce CPDs in xeroderma pigmentosum A knock-out mice,
which are deficient in nucleotide excision repair (de Vries
et al., 1995). Similarly, IL-12 did not prevent the induction of
UVR-Treg in xeroderma pigmentosum A knock-out mice.
This provided a first link between UVR-induced DNA
damage and the induction of UVR-Treg. In this context, it is
important to mention that UVR-induced DNA damage
has been favoured as the major molecular trigger for
UVR-induced immunosuppression for quite a long time
(Kripke et al., 1992; Nishigori et al., 1996).
It is striking that UVR-induced immunosuppression is
caused by rather low UVR doses (Toews et al., 1980) that are
suberythemogenic and thus in the physiological range. For a
long time it was thought that UVR depletes LC from the
epidermis simply by killing LCs. This does not appear to be
the case. The vast majority of LCs emigrate from the
epidermis on application of such UVR doses and can be
found in the regional lymph nodes (Vink et al., 1996;
Schwarz et al., 2005). Initially, it was thought that Langerin is
a specific marker for LCs (Valladeau et al., 2000; Takahara
et al., 2002), which is not the case as a distinct subtype of
dDC was also found to express Langerin (Bursch et al., 2007;
Ginhoux et al., 2007; Poulin et al., 2007; Nagao et al., 2009).
Hence, the appearance of Langerin-positive cells in the
lymph nodes does not automatically imply that these are
exclusively LCs, as they could also represent Langerin-
positive dDCs. CPDs, the major DNA damage induced by
the mid-wave UVR spectrum (UVB, 290–320 nm), can be
detected by a specific antibody. The major part of UVB is
absorbed in the epidermis and only a minor fraction
penetrates into the dermis. Thus, cells found in the lymph
nodes containing high levels of CPDs most likely originate
from the epidermis. As these cells coexpress Langerin, they
highly likely represent LCs.
Antigen-specific Treg can also be induced by extracorpor-
eal photopheresis. In this setting, mononuclear cells obtained
from hapten-sensitized mice are exposed in vitro to long
wave UVR (UVA, 320–400nm) in combination with the
photosensitizer 8-methoxypsoralen (Dani and Knobler,
2009). Infusion of these cells induces hapten-specific Treg
in the recipients (Maeda et al., 2005, 2008b). Extracorporeal
photopheresis-induced Treg are less well characterized than
UVR-Treg, but as of today they appear to be quite similar. It is
known that the combination of UVA plus 8-methoxypsoralen
induces apoptosis (Enomoto et al., 1997). However, CD11þ
cells that have been shown to be essential for the induction
of Treg (Maeda et al., 2005) undergo apoptosis on UVA plus
8-methoxypsoralen exposure much later than T cells; they die
only after 72 hours. Hence, in the setting of extracorporeal
photopheresis, viable but certainly damaged dendritic cells
are infused. This gave rise to the hypothesis that damaged but
still viable antigen-presenting cells are crucial for the
development of Treg and that the same may apply for
the induction of UVR-Treg.
This suggested that the induction of UVR-Treg is an active
process that requires viable antigen-presenting cells which,
however, are damaged and thus impaired in their antigen-
presenting function. This does not result in priming and the
development of effector T cells but in tolerance through
induction of Treg. We postulated that, if this hypothesis is
correct, a stimulus that kills LCs should not induce Treg. An
obvious option to test this postulate would be to increase the
UVR dose beyond the physiological range, which then would
immediately kill LCs. However, this experiment cannot be
performed as it is known that higher doses of UVR induce the
release of immunosuppressive cytokines, such as IL-10 from
keratinocytes, which then causes systemic immunosuppres-
sion (Ullrich and Schmitt, 2000). Under such conditions,
CHS is also suppressed and Treg develop as well. Therefore,
we used as an alternative stimulus topical steroids, which are
known to induce apoptosis of LCs (Hoetzenecker et al.,
2004). Accordingly, no LCs were detected in ear sheets after
mometasone application and no Langerin-positive cells were
found in the regional lymph nodes. Hence, we hypothesized
that steroids due to killing of LCs will prevent sensitization
but in contrast to UVR not induce Treg. This appears to be the
case. Application of DNFB onto mometasone-pretreated skin
did not result in sensitization and Treg failed to develop as
demonstrated by adoptive transfer experiments. However,
one could argue that mometasone does not exclusively kill
LCs and may affect also other cells both in the epidermis and
dermis. Although supporting our hypothesis this experimental
approach did not definitely prove that LCs are required for the
development of UVR-Treg.
Hence, we used Langerin-DTR mice. We surmised that if
LCs are crucial for the development of UVR-Treg, Langerin-
DTR mice should not develop Treg on UVR exposure. First,
we had to check whether Langerin-DTR mice could be
sensitized against DNFB. This was the case, though the
response was weaker than in wild-type mice as reported
previously (Bennett et al., 2005, 2007). Topical steroids also
inhibited sensitization in LC-depleted mice (data not shown).
Most surprisingly Langerin-DTR mice were not at all
suppressed in their sensitization response on UVR exposure.
The response was equal to that of LC-depleted positive
control mice, which were only sensitized and challenged.
Similarly, UVR-Treg did not develop, confirming the hypoth-
esis that LCs are essentially required for the development of
UVR-Treg.
However, Langerin is not any longer accepted as an
exclusive marker for LCs. It has turned out that Langerin is
also expressed by dDC (Merad et al., 2008). On injection
with DT, the latter cells are depleted as well. Thus,
involvement of dDC in the induction of UVR-Treg could
not be excluded. On depletion by DT, dDC repopulate within
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10 days, whereas LCs appear in the epidermis after several
weeks (Bursch et al., 2007; Ginhoux et al., 2007; Poulin
et al., 2007; Nagao et al., 2009; M Noordegraaf et al.,
submitted). Because of these differential kinetics, it is possible
to discern functions of Langerin-positive dDCs and LCs.
Langerin-DTR mice were injected with DT 10 days before
UVR exposure. Under these conditions, mice already harbor
Langerin-positive dDCs but not LCs when exposed to UVR. If
dDCs suffice to induce UVR-Treg, cells obtained from such
mice should suppress in an adoptive transfer experiment.
However, this was not the case. Ten day-DT Langerin-DTR
mice behaved identically as compared with Langerin-DTR
mice that received DT immediately before UVR exposure.
This indicates that LCs are relevant for the induction of UVR-
Treg. In addition, inhibition of the induction of CHS by UVR
was not observed in 10d-DT Langerin-DTR mice. This
implies that not only the induction of UVR-Treg but also
the inhibition of the induction of CHS is critically dependent
on LCs.
During the submission of this manuscript, a paper was
published which, in contrast to our findings, reported that LCs
are not involved in UVR-induced immunosuppression (Wang
et al., 2009). However, this publication only referred to the
suppression of the induction of CHS by UVR. Adoptive
transfer experiments were not performed. Hence, the role of
LCs in the induction of Treg remains unclear in this paper. For
the depletion of LC, Langerin-DTR knock-in mice were used
(Kissenpfennig et al., 2005). In most of the experiments,
epicutaneous sensitization against ovalbumin and transfer of
OT-I cells were used as an immunological model. There is
ample evidence that this system cannot be compared with the
hapten-induced CHS (Herrick et al., 2003). Only two
experiments were performed with a similar CHS model as
we used. However, lower UVR doses and lower hapten
concentrations were applied, which might account for the
differences in the results. In addition, the authors claimed that
UVR does not deplete LC, which is quite in contrast to the
literature (Ko¨lgen et al., 2003). The presence of LC was
monitored in epidermal cell suspensions but not evaluated in
ear sheets. Probably, the UVR dose applied was too low to
deplete the LC in this setting. Taken together, it appears that
the discrepancies to our results may be mostly due to the
differences in the methods.
For a long time, LCs have been considered as the exclusive
antigen-presenting cells of the skin (Romani and Schuler,
1992). This concept, however, has recently changed quite
dramatically. There is accumulating evidence that immune
responses can be generated in the skin in the absence of LC
(Bennett et al., 2005; Kaplan et al., 2005; Kissenpfennig et al.,
2005) and that antigen-presenting cells in the dermis can be
more relevant than LCs (Allan et al., 2003; Ritter et al., 2004).
Hence, the concept arose that LCs are more involved in
downregulating immune responses (Kaplan et al., 2008;
Udey and Rosenberg, 2008). From a clinical point of view
this would make sense, as T cell responses in the skin appear
to be more hazardous than protective. The vast majority of
inflammatory dermatoses is T cell-driven (Robert and Kupper,
1999). Patients with T cell defects do not suffer from major
skin infections, as the innate immune system is much more
relevant for the skin defense. Accordingly, in contrast to the
adaptive, the innate immune response is induced by UVR as
recently demonstrated by the induction of antimicrobial
peptides, an essential component of the innate immune
system (Gla¨ser et al., 2009). In contrast, the skin is constantly
exposed to contact allergens and represents an organ prone to
autoimmunity (Seery et al., 1997; Mehling et al., 2001).
Hence, a constant downtuning of the adaptive immune
system may be beneficial (Schwarz, 2010). This may be
achieved by physiological UVR doses and, as confirmed by
the present findings, LCs appear to be an essential part of this
regulatory system.
MATERIALS AND METHODS
Mice and reagents
Eight- to ten-week-old female C57BL/6 mice were purchased from
Charles River Laboratories (Sulzfeld, Germany). Langerin-DTR mice
were generated by B.E. Clausen (Bennett et al., 2005) and bred in the
central animal facilities of the University Clinics Schleswig-Holstein,
Campus Kiel. To deplete Langerin-positive cells, mice were injected
with DT (Sigma–Aldrich, Taufkirchen, Germany) intraperitoneally
and subcutaneously (400 ng each). Mometasone was obtained from
Essex Pharma (Munich, Germany), and applied on razor-shaved skin
(0.1% for 4 days). Animal care was provided by expert personnel in
compliance with the relevant laws and institutional guidelines.
UVR-induced immunosuppression
UVR-induced immunosuppression was induced by irradiating the
shaved backs of mice with 150mJ cm2 UVR daily on 4 consecutive
days. UV irradiation was performed using a bank of six fluorescent
bulbs (TL12, Philips, Eindhoven, The Netherlands), which emit most
of their energy within the UVB range (290–320 nm) with an emission
peak at 313 nm. After 24 hours of the last UVR exposure, mice were
sensitized by painting 50 ml of DNFB (Sigma–Aldrich) solution (0.5%
in acetone/olive oil, 4:1) on their backs. Five days after sensitization,
mice were challenged with 20 ml of 0.3% DNFB on the left ear. The
ear swelling response was quantified with a spring-loaded micro-
meter 24 hours later. Positive control mice were sensitized and
challenged. Negative controls were challenged only. CHS was
determined as the amount of swelling of the hapten-challenged ear
compared with the thickness of the vehicle-treated ear and expressed
in cm  103.
Generation of UVR-Treg
Mice were sensitized against DNFB through UVR-exposed skin as
described above. After challenge on day 5 and measurement of ear
swelling on day 6, spleens and regional lymph nodes were removed
and single cell suspensions prepared. 1 108 cells were injected
intravenously through tail veins into naive wild-type mice. Reci-
pients were sensitized against DNFB 24 hours after injection and ear
challenge was performed 5 days later. After 24 hours, ear swelling
was measured.
Staining of ear sheets and FACS analysis
Ears were obtained and mechanically split into dorsal and ventral
sides. Sheets were floated on phosphate-buffered saline (PBS)
containing 20mM EDTA (pH 7.4) at 37 1C for 3.5 hours. After
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washing with PBS, the dermis was removed and the epidermal sheets
were spread floating on PBS in a Petri dish and subsequently fixed in
acetone for 20minutes at 20 1C. After briefly washing in PBS,
epidermal sheets were blocked with PBS supplemented with 1% fetal
calf serum for 1hour at room temperature. Subsequently a phycoer-
yhtrin-conjugated mAb recognizing IA/IE (murine major histocompat-
ability complex class II) (clone M5/114, Becton Dickinson, Franklin
Lakes, NJ) was added (dilution 1:100) and incubated overnight at 4 1C.
An appropriate isotype control was included. After washing in PBS for
1 hour at room temperature, ear sheets were mounted using Kaiser’s
glycerol gelatin (Merck, Darmstadt, Germany). Immunofluorescence
staining was analyzed using a Zeiss Axiovert 40 CFL microscope (Carl
Zeiss, Go¨ttingen, Germany).
Twenty-four hours after the last mometasone application draining
lymph nodes were obtained. Cell suspensions were stained with
FITC-conjugated anti-CD11c mAb (BD Bioscience, San Diego, CA).
Subsequently, cells were fixed and permeabilized using BD cytofix/
cytoperm plus kit (BD Bioscience) according to the manufacturer’s
instruction, followed by intracellular staining with an allophycocya-
nin-conjugated anti-Langerin antibody (clone 929F3.01, Dendritics,
Lyon, France). Cells were analyzed by an FC 500 CXP FACS analyzer
(Beckman Coulter, Krefeld, Germany).
Statistics
Data were analyzed by Student’s t-test. Differences were considered
significant at Po0.05.
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